戻る Agendas
Session 0803 Breakthrough Therapies in Diabetes Diseases
Session Chair(s)
Yan Gong
Senior Global Clinical Program Lead, Corporate Division of Medicine
Boehringer-Ingelheim, Germany, China
Huaqiong SHEN, MD, PHD
Chief Medical Officer
Jiangsu Hengrui Medicine Co., Ltd., China
Speaker(s)
Diabetes Treatment - Insulin and GLP-1
Kezhou Zhang
Novo Nordisk (China) Pharmaceuticals Co. Ltd., China
Vice President, Clinical & Medical & Regulatory
Recent advancement of drug development in diabetes - synthetic chemical entity
ShuHua SHANG
sanofi, China
Clinical Research Director
Yan Gong
Boehringer-Ingelheim, Germany, China
Senior Global Clinical Program Lead, Corporate Division of Medicine
Status Quo, Challenges and Opportunities for Domestic Companies in Diabetes Therapies
Eric Hua
Gan & Lee Pharmaceuticals, China
Overseas Clinical Project Manager, Clinical Operations
Pipeline in Diabetes – From the Industrial Perspective (EN&CN)
Chengyu Guan
Jiangsu Hengrui Medicine Co., Ltd, China, China
Medical Director